{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:24:32Z","timestamp":1793755472998,"version":"4.6.1"},"reference-count":89,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jacadv.2024.101131","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T17:19:25Z","timestamp":1722446365000},"page":"101131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"P1","title":["From Hospital to Home"],"prefix":"10.1016","volume":"3","author":[{"given":"Suzanne","family":"Oskouie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambarish","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Mullens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahzeb","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran L.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy M.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8370-4569","authenticated-orcid":false,"given":"Harriette GC.","family":"Van Spall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jacadv.2024.101131_bib1","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/ehjqcco\/qcac088","article-title":"Sex differences in the Etiology and burden of heart failure across Country income level: analysis of 204 countries and Territories 1990-2019","volume":"9","author":"Wei","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jacadv.2024.101131_bib2","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1002\/ehf2.14076","article-title":"Impact analysis of heart failure across European countries: an ESC-HFA position paper","volume":"9","author":"Rosano","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib3","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/jama.2019.0710","article-title":"Effect of patient-Centered transitional care services on clinical outcomes in patients hospitalized for heart failure: the PACT-HF randomized clinical trial","volume":"321","author":"Van Spall","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacadv.2024.101131_bib4","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jchf.2023.04.017","article-title":"Mortality, outcomes, costs, and Use of Medicines following a first heart failure hospitalization: EVOLUTION HF","volume":"11","author":"Bozkurt","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib5","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: Executive summary: a Report of the American College of cardiology\/American heart association Joint Committee on clinical practice guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2024.101131_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.cardfail.2021.09.012","article-title":"The association between socioeconomic status, Sex, Race\/Ethnicity and in-hospital mortality among patients hospitalized for heart failure","volume":"28","author":"Averbuch","year":"2022","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion - a position statement from the Heart\u00a0Failure Association of the European Society of Cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2024.101131_bib9","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.jacadv.2024.101131_bib10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/ehjqcco\/qcac015","article-title":"Urinary sodium: worth its salt?","volume":"8","author":"Averbuch","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jacadv.2024.101131_bib11","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1038\/s41591-023-02532-z","article-title":"Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial","volume":"29","author":"Ter Maaten","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jacadv.2024.101131_bib12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.109.933275","article-title":"Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival","volume":"122","author":"Testani","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2024.101131_bib13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1001\/jama.2022.23924","article-title":"Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: the TRANSFORM-HF randomized clinical trial","volume":"329","author":"Mentz","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jacadv.2024.101131_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/eurheartj\/ehac689","article-title":"Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial","volume":"44","author":"Trulls","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2024.101131_bib15","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide in acute decompensated heart failure with volume Overload","volume":"387","author":"Mullens","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2024.101131_bib16","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","article-title":"Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial","volume":"2","author":"Butler","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"31","key":"10.1016\/j.jacadv.2024.101131_bib17","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1093\/eurheartj\/ehad341","article-title":"Dapagliflozin versus metolazone in heart failure resistant to loop diuretics","volume":"44","author":"Ern Yeoh","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2024.101131_bib18","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/ejhf.1478","article-title":"Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance","volume":"21","author":"Verbrugge","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.122.059038","article-title":"Effects of early empagliflozin initiation on diuresis and kidney function in patients with acute decompensated heart failure (EMPAG-HF)","volume":"146","author":"Schulze","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2024.101131_bib20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/ejhf.1713","article-title":"Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF)","volume":"22","author":"Damman","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/ehac530","article-title":"Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial","volume":"44","author":"Biegus","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2024.101131_bib22","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacadv.2024.101131_bib23","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.jacc.2016.12.035","article-title":"Short-term effects of tolvaptan in patients with acute heart failure and volume Overload","volume":"69","author":"Konstam","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2024.101131_bib24","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2016.09.004","article-title":"Efficacy and safety of tolvaptan in patients hospitalized with acute heart failure","volume":"69","author":"Felker","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2024.101131_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jchf.2015.08.005","article-title":"Aquapheresis versus intravenous diuretics and hospitalizations for heart failure","volume":"4","author":"Costanzo","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib26","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2024.101131_bib27","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.jacc.2017.03.528","article-title":"Extracorporeal ultrafiltration for fluid Overload in heart failure: current status and Prospects for Further research","volume":"69","author":"Costanzo","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2024.101131_bib28","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.2019.18598","article-title":"Effect of a strategy of comprehensive vasodilation vs usual care on mortality and heart failure Rehospitalization among patients with acute heart failure: the GALACTIC randomized clinical trial","volume":"322","author":"Kozhuharov","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacadv.2024.101131_bib29","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/jama.2013.282190","article-title":"Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial","volume":"310","author":"Chen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacadv.2024.101131_bib30","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cjca.2017.08.022","article-title":"2017 comprehensive update of the Canadian cardiovascular society guidelines for the management of heart failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacadv.2024.101131_bib31","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/jama.294.13.1625","article-title":"Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial","volume":"294","author":"Binanay","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacadv.2024.101131_bib32","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jchf.2020.08.012","article-title":"Complete hemodynamic profiling with pulmonary artery catheters in Cardiogenic shock is associated with lower in-hospital mortality","volume":"8","author":"Garan","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000448110","article-title":"Impact of pulmonary artery catheter Use on short- and long-term mortality in patients with Cardiogenic shock","volume":"136","author":"Rossello","year":"2017","journal-title":"Cardiology"},{"issue":"37","key":"10.1016\/j.jacadv.2024.101131_bib34","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2024.101131_bib35","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/ejhf.2248","article-title":"Risk and risk reduction in trials of heart failure with reduced ejection fraction: absolute or relative?","volume":"23","author":"Van Spall","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib36","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2024.101131_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2023.04.019","article-title":"Angiotensin-neprilysin inhibition in patients with mildly reduced or preserved ejection fraction and worsening heart failure","volume":"82","author":"Mentz","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2024.101131_bib38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2024.101131_bib39","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial","volume":"28","author":"Voors","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jacadv.2024.101131_bib40","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2024.101131_bib41","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacadv.2024.101131_bib42","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2024.101131_bib43","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2024.101131_bib44","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jchf.2015.03.008","article-title":"Effects of beta-blocker Withdrawal in acute decompensated heart failure: a systematic review and meta-analysis","volume":"3","author":"Prins","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib45","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2024.101131_bib46","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa2304968","article-title":"Ferric carboxymaltose in heart failure with iron deficiency","volume":"389","author":"Mentz","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2024.101131_bib47","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/CIRCULATIONAHA.121.052792","article-title":"Evidence-based medical therapy in patients with heart failure with reduced ejection fraction and chronic kidney disease","volume":"145","author":"Beldhuis","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2024.101131_bib48","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ejhf.2471","article-title":"Renal effects of guideline-directed medical therapies in heart failure: a consensus document from the Heart\u00a0Failure Association of the European Society of Cardiology","volume":"24","author":"Mullens","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib49","doi-asserted-by":"crossref","first-page":"385","DOI":"10.7326\/M20-5938","article-title":"Diabetes management in chronic kidney disease: Synopsis of the 2020 KDIGO clinical practice guideline","volume":"174","author":"Navaneethan","year":"2021","journal-title":"Ann Intern Med"},{"issue":"19","key":"10.1016\/j.jacadv.2024.101131_bib50","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jacc.2023.08.026","article-title":"Dapagliflozin in patients with heart failure and deterioration in estimated glomerular filtration rate to\u00a0<25ml\/min\/1.73m(2)","volume":"82","author":"Chatur","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2024.101131_bib51","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1161\/CIRCULATIONAHA.121.057736","article-title":"Sodium-glucose cotransporter 2 inhibitors and risk of hyperkalemia in people with type 2 diabetes: a meta-analysis of individual participant data from randomized, controlled trials","volume":"145","author":"Neuen","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2024.101131_bib52","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1093\/eurheartj\/ehac401","article-title":"Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial","volume":"43","author":"Butler","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2024.101131_bib53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12882-022-03054-5","article-title":"Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia","volume":"24","author":"Kanda","year":"2023","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jacadv.2024.101131_bib54","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/00015385.2020.1748346","article-title":"The importance of developing hyperkalaemia in heart failure during long-term follow-up","volume":"76","author":"Martens","year":"2021","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.jacadv.2024.101131_bib55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijcard.2022.10.129","article-title":"Low blood pressure and guideline-directed medical therapy in patients with heart failure with reduced ejection fraction","volume":"370","author":"Izumi","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacadv.2024.101131_bib56","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacadv.2024.101131_bib57","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2024.101131_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89752-w","article-title":"SGLT-2 inhibitors associated euglycemic and hyperglycemic DKA in a multicentric cohort","volume":"11","author":"Ata","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacadv.2024.101131_bib59","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1161\/CIR.0000000000000920","article-title":"Cardiorenal Protection with the Newer Antidiabetic Agents in patients with diabetes and chronic\u00a0kidney disease: a Scientific statement from the American heart association","volume":"142","author":"Rangaswami","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2024.101131_bib60","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacadv.2024.101131_bib61","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jchf.2022.08.012","article-title":"Hemodynamically-guided management of heart failure across the ejection fraction Spectrum: the GUIDE-HF trial","volume":"10","author":"Zile","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib62","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jchf.2021.12.004","article-title":"Frailty, guideline-directed medical therapy, and outcomes in HFrEF: from the GUIDE-IT trial","volume":"10","author":"Khan","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib63","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jchf.2019.10.003","article-title":"Frailty among older decompensated heart failure patients: prevalence, association with patient-Centered outcomes, and Efficient Detection methods","volume":"7","author":"Pandey","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1179253","article-title":"Generic cardiology drug prices: the potential benefits of the Marc Cuban cost plus drug company model","volume":"14","author":"Narendrula","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacadv.2024.101131_bib65","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2019.03.467","article-title":"Deprescribing in older adults with cardiovascular disease","volume":"73","author":"Krishnaswami","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2024.101131_bib66","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.hrthm.2023.03.1538","article-title":"2023 HRS\/APHRS\/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure","volume":"20","author":"Chung","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacadv.2024.101131_bib67","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2024.101131_bib68","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2024.101131_bib69","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2024.101131_bib70","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2024.101131_bib71","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJMoa2300525","article-title":"Transcatheter repair for patients with tricuspid regurgitation","volume":"388","author":"Sorajja","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2024.101131_bib72","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ejhf.3150","article-title":"Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart\u00a0Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)","volume":"26","author":"Mullens","year":"2024","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.jacadv.2024.101131_bib73","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/ejhf.3215","article-title":"Interatrial shunt therapy in advanced heart failure: outcomes from the open-label cohort of the RELIEVE-HF trial","volume":"26","author":"Rod\u00e9s-Cabau","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib74","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0140-6736(22)00016-2","article-title":"Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial","volume":"399","author":"Shah","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jacadv.2024.101131_bib75","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jchf.2018.04.010","article-title":"A\u00a0randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation","volume":"6","author":"Abraham","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"4","key":"10.1016\/j.jacadv.2024.101131_bib76","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/ejhf.3232","article-title":"Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: long-term outcomes","volume":"26","author":"Zile","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib77","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa2026141","article-title":"Physical rehabilitation for older patients hospitalized for heart failure","volume":"385","author":"Kitzman","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2024.101131_bib78","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamacardio.2022.4903","article-title":"Frailty and effects of a Multidomain physical rehabilitation intervention among older patients hospitalized for acute heart failure: a secondary analysis of a randomized clinical trial","volume":"8","author":"Pandey","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacadv.2024.101131_bib79","doi-asserted-by":"crossref","first-page":"e699","DOI":"10.1161\/CIR.0000000000001122","article-title":"Supervised exercise Training for chronic heart failure with preserved ejection fraction: a Scientific statement from the American heart association and American College of cardiology","volume":"147","author":"Sachdev","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2024.101131_bib80","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1503\/cmaj.050626","article-title":"What matters most in end-of-life care: perceptions of seriously ill patients and their family members","volume":"174","author":"Heyland","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.jacadv.2024.101131_bib81","article-title":"Temporal Trends and Sex differences in intensity of healthcare at the end of life in adults with heart failure","volume":"10","author":"Van Spall","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacadv.2024.101131_bib82","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jacc.2022.04.057","article-title":"Criteria for referral of patients with advanced heart failure for Specialized palliative care","volume":"80","author":"Chang","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2024.101131_bib83","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/ehf2.13344","article-title":"Clinical phenogroups are more effective than left ventricular ejection fraction categories in stratifying heart failure outcomes","volume":"8","author":"Gevaert","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib84","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/ehf2.13109","article-title":"The LENT index predicts 30\u00a0day outcomes following hospitalization for heart failure","volume":"8","author":"Van Spall","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib85","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/ejhf.765","article-title":"Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure: a systematic review and network meta-analysis","volume":"19","author":"Van Spall","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib86","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jama.2021.8844","article-title":"Effect of a hospital and Postdischarge quality improvement intervention on clinical outcomes and quality of care for patients with heart failure with reduced ejection fraction: the CONNECT-HF randomized clinical trial","volume":"326","author":"DeVore","year":"2021","journal-title":"JAMA"},{"issue":"10367","key":"10.1016\/j.jacadv.2024.101131_bib87","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jacadv.2024.101131_bib88","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ejhf.3134","article-title":"Effect of a transitional care model following hospitalization for heart failure: 3-year outcomes of the Patient-Centered Care Transitions in Heart\u00a0Failure (PACT-HF) randomized controlled trial","volume":"26","author":"Averbuch","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101131_bib89","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jacc.2023.02.005","article-title":"Cluster-randomized trial comparing ambulatory Decision support tools to improve heart failure care","volume":"81","author":"Mukhopadhyay","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X24003260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X24003260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T20:19:06Z","timestamp":1726690746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X24003260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":89,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2772963X24003260"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2024.101131","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From Hospital to Home","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2024.101131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101131"}}